Latest Breaking News On - சர்வதேச சமூகம் க்கு காந்த அதிர்வு இல் மருந்து - Page 1 : comparemela.com

May 18, 2021 Up to 40% of COVID-19 survivors experience long-term neurological conditions, and it s crucial that radiologists understand these, according to a May 17 presentation at the International Society for Magnetic Resonance in Medicine (ISMRM) 2021 virtual annual meeting. The good news is that MRI has shown itself to be an effective way to track COVID-19 s lasting neurological effects, according to presenter Dr. Simonetta Gerevini of Azienda Ospedaliera Papa Giovanni XXIII hospital in Bergamo, Italy. Neuroimaging can illuminate a spectrum of central nervous system abnormalities, from ischemic lesions and microhemorrhages to meningoencephalitis and white matter lesions, she noted. Long-term neurological and neuropsychological sequelae are reported in up to 30% to 40% of COVID-19 survivors. Symptoms can include fatigue, myalgia, headache, dysautonomia, and cognitive impairment, according to Gerevini.

Azienda ospedaliera papa giovanniSimonetta gereviniInternational society for magnetic resonance in medicineInternational societyMagnetic resonanceசர்வதேச சமூகம் க்கு காந்த அதிர்வு இல் மருந்துசர்வதேச சமூகம்காந்த அதிர்வு